Class / Patent application number | Description | Number of patent applications / Date published |
514360000 | Plural ring chalcogens in the hetero ring | 9 |
20090170910 | WOUND HEALING - The present invention relates to the use of p38 MAP kinase inhibitors and p38 MAP kinase inhibition to promote wound healing. | 07-02-2009 |
20090239914 | Phosphorus binder for treatment of renal disease - The present invention relates to oral compositions which are useful for binding phosphorus in ingesta, and inhibiting absorption of phosphorus from the gastrointestinal tract of subjects. A method for binding phosphorus in ingesta and inhibiting its absorption from the gastrointestinal tract is also provided. The dietary supplements and pharmaceutical products and methods of the present invention are particularly useful in the treatment of hyperphosphatemia of chronic uremia and reducing serum phosphorus levels in patients requiring such therapy. | 09-24-2009 |
20100168189 | THERAPEUTIC SUBSTITUTED LACTAMS - Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein. | 07-01-2010 |
20100234434 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS - Disclosed herein are compounds, compositions and methods for treating or ameliorating flavivirus infections. This is particularly important because the present disclosure provides methods for treating flavivirus infections for which there is no effective vaccine. | 09-16-2010 |
20110288136 | FLAVIVIRUS INHIBITION BY SULTAMS AND RELATED COMPOUNDS - Disclosed herein are compounds, compositions and methods for treating or ameliorating flavivirus infections. This is particularly important because the present disclosure provides methods for treating flavivirus infections for which there is no effective vaccine. | 11-24-2011 |
20130165485 | INSECTICIDAL COMPOUNDS - A compound of formula (I): | 06-27-2013 |
20150313823 | CATIONIC PYRITHIONE DISPERSION - The present invention provides a cationic dispersion containing pyrithione compound, water and a cationic surfactant. The cationic surfactant is present in an amount sufficient to disperse the pyrithione in water. The dispersion is useable as an additive to personal care compositions, such as conditioners. | 11-05-2015 |
20150336916 | EPOXYEICOSATRIENOIC ACID ANALOGS AND METHODS OF MAKING AND USING THE SAME - Compounds and compositions comprising epoxyeicosatrienoic acid (EET) analogs that act as EET agonists and are useful as medications in the treatment of drug-induced nephrotoxicity, hypertension and other related conditions. Methods of making and using the compounds and compositions are further described. | 11-26-2015 |
20190142810 | MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS | 05-16-2019 |